Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 7;15(8):1174-1178.
doi: 10.2215/CJN.05170420. Epub 2020 May 18.

Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019

S Ali Husain  1   2 , Geoffrey Dube  1 , Heather Morris  1 , Hilda Fernandez  1 , Jae-Hyung Chang  1 , Kathryn Paget  1 , Sharlinee Sritharan  1 , Shefali Patel  1 , Olga Pawliczak  1 , Mia Boehler  1 , Demetra Tsapepas  2   3 , R John Crew  1 , David J Cohen  1 , Sumit Mohan  1   2   4
Affiliations

Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019

S Ali Husain et al. Clin J Am Soc Nephrol. .

Abstract

Background and objectives: Outcomes of kidney transplant recipients diagnosed with coronavirus disease 2019 as outpatients have not been described.

Design, setting, participants, & measurements: We obtained clinical data for 41 consecutive outpatient kidney transplant recipients with known or suspected coronavirus disease 2019. Chi-squared and Wilcoxon rank sum tests were used to compare characteristics of patients who required hospitalization versus those who did not.

Results: Of 41 patients, 22 (54%) had confirmed coronavirus disease 2019, and 19 (46%) were suspected cases. Patients most commonly reported fever (80%), cough (56%), and dyspnea (39%). At the end of follow-up, 13 patients (32%) required hospitalization a median of 8 days (range, 1-16) after symptom onset, and 23 (56%) had outpatient symptom resolution a median of 12 days (4-23) after onset. Patients who required hospitalization were more likely to have reported dyspnea (77% versus 21%, P=0.003) and had higher baseline creatinine (median, 2.0 versus 1.3 mg/dl, P=0.02), but there were no other differences between groups.

Conclusions: In an early cohort of outpatient kidney transplant recipients with known or suspected coronavirus disease 2019, many had symptomatic resolution without requiring hospitalization.

Keywords: COVID-19; Cohort Studies; Dyspnea; Nonparametric; Outpatients; SARS-CoV2; Statistics; coronavirus; creatinine; hospitalization; kidney transplantation; severe acute respiratory syndrome coronavirus 2.

PubMed Disclaimer

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment in

References

    1. WHO: Coronavirus Disease 2019 (COVID-19) Situation Report–85, 2020. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed April 14, 2020
    1. Ahmadpoor P, Rostaing L: Why the immune system fails to mount an adaptive immune response to a COVID-19 infection [published online ahead of print April 1, 2020]. Transpl Int doi:10.1111/tri.13611 - PubMed
    1. Cheng KW, Cheng SC, Chen WY, Lin MH, Chuang SJ, Cheng IH, Sun CY, Chou CY: Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus. Antiviral Res 115: 9–16, 2015. - PMC - PubMed
    1. Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, Maffei C, Possenti S, Zambetti N, Moscato M, Venturini M, Affatato S, Gaggiotti M, Bossini N, Scolari F: A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia [published online ahead of print April 9, 2020]. Kidney Int doi:10.1016/j.kint.2020.04.002 - PMC - PubMed
    1. Banerjee D, Popoola J, Shah S, Ster IC, Quan V, Phanish M: COVID-19 infection in kidney transplant recipients [published online ahead of print April 9, 2020]. Kidney Int doi:10.1016/j.kint.2020.03.018 - PMC - PubMed

Publication types

Substances